77 related articles for article (PubMed ID: 20519144)
21. Distinct pathways of ERK activation by the muscarinic agonists pilocarpine and carbachol in a human salivary cell line.
Lin AL; Zhu B; Zhang W; Dang H; Zhang BX; Katz MS; Yeh CK
Am J Physiol Cell Physiol; 2008 Jun; 294(6):C1454-64. PubMed ID: 18385290
[TBL] [Abstract][Full Text] [Related]
22. Signalling pathway leading to an activation of mitogen-activated protein kinase by stimulating M3 muscarinic receptor.
Kim JY; Yang MS; Oh CD; Kim KT; Ha MJ; Kang SS; Chun JS
Biochem J; 1999 Jan; 337 ( Pt 2)(Pt 2):275-80. PubMed ID: 9882625
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological and functional characterization of muscarinic receptor subtypes in developing oligodendrocytes.
Ragheb F; Molina-Holgado E; Cui QL; Khorchid A; Liu HN; Larocca JN; Almazan G
J Neurochem; 2001 Jun; 77(5):1396-406. PubMed ID: 11389190
[TBL] [Abstract][Full Text] [Related]
24. Local anesthetics inhibit muscarinic receptor-mediated activation of extracellular signal-regulated kinases in rat pheochromocytoma PC12 cells.
Tan Z; Dohi S; Ohguchi K; Nakashima S; Nozawa Y
Anesthesiology; 1999 Oct; 91(4):1014-24. PubMed ID: 10519505
[TBL] [Abstract][Full Text] [Related]
25. Differential regulation of mTOR-dependent S6 phosphorylation by muscarinic acetylcholine receptor subtypes.
Slack BE; Blusztajn JK
J Cell Biochem; 2008 Aug; 104(5):1818-31. PubMed ID: 18348264
[TBL] [Abstract][Full Text] [Related]
26. M
Chen S; Liao B; Jin X; Wei T; He Q; Lin Y; Ai J; Gong L; Li H; Wang K
J Cell Biochem; 2020 Nov; 121(11):4496-4504. PubMed ID: 32065420
[TBL] [Abstract][Full Text] [Related]
27. Evidence for operation of nicotinic and muscarinic acetylcholine receptor-dependent survival pathways in human coronary artery endothelial cells.
Smedlund K; Tano JY; Margiotta J; Vazquez G
J Cell Biochem; 2011 Aug; 112(8):1978-84. PubMed ID: 21541985
[TBL] [Abstract][Full Text] [Related]
28. 3-iodothyronamine (T1AM), a novel antagonist of muscarinic receptors.
Laurino A; Matucci R; Vistoli G; Raimondi L
Eur J Pharmacol; 2016 Dec; 793():35-42. PubMed ID: 27815171
[TBL] [Abstract][Full Text] [Related]
29. Muscarinic control of MIN6 pancreatic β cells is enhanced by impaired amino acid signaling.
Guerra ML; Wauson EM; McGlynn K; Cobb MH
J Biol Chem; 2014 May; 289(20):14370-9. PubMed ID: 24695728
[TBL] [Abstract][Full Text] [Related]
30. Acetylcholine acts through M3 muscarinic receptor to activate the EGFR signaling and promotes gastric cancer cell proliferation.
Yu H; Xia H; Tang Q; Xu H; Wei G; Chen Y; Dai X; Gong Q; Bi F
Sci Rep; 2017 Jan; 7():40802. PubMed ID: 28102288
[TBL] [Abstract][Full Text] [Related]
31. Identification and functional characterization of the muscarinic receptor M3 in the human keratinocyte cell line HaCaT.
Metzger M; Just L; Boss A; Drews U
Cells Tissues Organs; 2005; 180(2):96-105. PubMed ID: 16113538
[TBL] [Abstract][Full Text] [Related]
32. Acetylcholine mediates the release of IL-8 in human bronchial epithelial cells by a NFkB/ERK-dependent mechanism.
Profita M; Bonanno A; Siena L; Ferraro M; Montalbano AM; Pompeo F; Riccobono L; Pieper MP; Gjomarkaj M
Eur J Pharmacol; 2008 Mar; 582(1-3):145-53. PubMed ID: 18242599
[TBL] [Abstract][Full Text] [Related]
33. Muscarinic cholinergic receptors activate both inhibitory and stimulatory growth mechanisms in NIH3T3 cells.
Nicke B; Detjen K; Logsdon CD
J Biol Chem; 1999 Jul; 274(31):21701-6. PubMed ID: 10419481
[TBL] [Abstract][Full Text] [Related]
34. Impaired M(3) muscarinic acetylcholine receptor signal transduction through blockade of binding of multiple proteins to its third intracellular loop.
Borroto-Escuela DO; Correia PA; Perez Alea M; Narvaez M; Garriga P; Fuxe K; Ciruela F
Cell Physiol Biochem; 2010; 25(4-5):397-408. PubMed ID: 20332620
[TBL] [Abstract][Full Text] [Related]
35. The paired activation of the two components of the muscarinic M3 receptor dimer is required for induction of ERK1/2 phosphorylation.
Novi F; Scarselli M; Corsini GU; Maggio R
J Biol Chem; 2004 Feb; 279(9):7476-86. PubMed ID: 14660647
[TBL] [Abstract][Full Text] [Related]
36. Altered trafficking and unfolded protein response induction as a result of M3 muscarinic receptor impaired N-glycosylation.
Romero-Fernandez W; Borroto-Escuela DO; Alea MP; Garcia-Mesa Y; Garriga P
Glycobiology; 2011 Dec; 21(12):1663-72. PubMed ID: 21798865
[TBL] [Abstract][Full Text] [Related]
37. Protection from interferon-β-induced neuronal apoptosis through stimulation of muscarinic acetylcholine receptors coupled to ERK1/2 activation.
Olianas MC; Dedoni S; Onali P
Br J Pharmacol; 2016 Oct; 173(19):2910-28. PubMed ID: 27474091
[TBL] [Abstract][Full Text] [Related]
38. MAPK pathway mediates muscarinic receptor-induced human lung fibroblast proliferation.
Matthiesen S; Bahulayan A; Holz O; Racké K
Life Sci; 2007 May; 80(24-25):2259-62. PubMed ID: 17383686
[TBL] [Abstract][Full Text] [Related]
39. Probing biochemical mechanisms of action of muscarinic M3 receptor antagonists with label-free whole cell assays.
Deng H; Wang C; Su M; Fang Y
Anal Chem; 2012 Oct; 84(19):8232-9. PubMed ID: 22954104
[TBL] [Abstract][Full Text] [Related]
40. M3 mAChR-mediated IL-8 expression through PKC/NF-κB signaling pathways.
Xu ZP; Song Y; Yang K; Zhou W; Hou LN; Zhu L; Chen HZ; Cui YY
Inflamm Res; 2014 Jun; 63(6):463-73. PubMed ID: 24522860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
